NASDAQ:TXMD | Free Cash Flow | TherapeuticsMD, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$944,000.00
2025-12-31$375,000.00
2025-03-31$699,000.00
2024-12-31$17,000.00
2024-03-31-$229,000.00
2023-12-31-$4.96M
2023-03-31-$8.7M
2022-12-31$73.21M
2022-03-31-$17.87M$42,000.00-$17.91M
2021-12-31-$39.56M$0.00-$39.56M
2021-03-31-$38.38M$63,000.00-$38.44M
2020-12-31-$30.36M$168,000.00-$30.53M
2020-03-31-$39.11M$21,000.00-$39.13M
2019-12-31-$50.82M$360,587.00-$51.18M
2019-03-31-$38.16M$262,418.00-$38.43M
2018-12-31-$28.14M$150,745.00-$28.3M
2018-03-31-$19.65M$26,908.00-$19.68M
2017-12-31-$20.81M$25,968.00-$20.83M
2017-03-31-$20.53M$27,834.00-$20.55M
2016-12-31-$15.62M$88,440.00-$15.71M
2016-03-31-$19.4M$74,478.00-$19.48M
2015-12-31-$16.61M$149,698.00-$16.76M
2015-03-31-$19.15M
2014-12-31-$15.29M$0.00-$15.29M
2014-03-31-$8.71M$23,692.00-$8.73M
2013-12-31-$4.77M$17,035.00-$4.79M
2013-03-31-$3.51M$22,905.00-$3.53M
2012-12-31-$4.01M-$2,499.00-$4.01M
2012-03-31-$2.45M$32,386.00-$2.48M
2011-12-31-$1.88M$0.00-$1.88M
2011-03-31-$760,737.00$10,913.00-$771,650.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$2.45M
2024-12-31$1.17M
2023-12-31-$23.08M
2022-12-31$9.36M
2021-12-31-$142.69M$34,000.00-$142.73M
2020-12-31-$159.47M$207,000.00-$159.68M
2019-12-31-$165.72M$2.45M-$168.17M
2018-12-31-$106.81M$217,040.00-$107.03M
2017-12-31-$76.16M$61,817.00-$76.22M
2016-12-31-$69.14M$396,154.00-$69.54M
2015-12-31-$79.04M$165,257.00-$79.21M
2014-12-31-$45.52M$30,962.00-$45.55M
2013-12-31-$20.77M$40,790.00-$20.81M
2012-12-31-$12.74M$66,405.00-$12.8M
2011-12-31-$4.97M$28,766.00-$5M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.